WAUKEGAN, Ill.--(BUSINESS WIRE)--Jan. 10, 2006--NeoPharm, Inc. (Nasdaq/NM:NEOL) today announced the completion of the sale of 4,025,000 shares of common stock at a public offering price of $10.20 per share. This amount includes the exercise in full of the underwriter's option to purchase 525,000 shares to cover over-allotments. All of the shares were offered by the Company. The net proceeds from the offering to the Company, after underwriting discounts and commissions and estimated expenses, were approximately $38.5 million. UBS Securities LLC acted as the sole manager of this offering.
